Exam (specific) Flashcards
Mary: Risk factors for COPD
- Smoking
- Environment: air pollutants and/or occupational irritants
- History of resp. infections during childhood and/or family history of COPD
- alpha1 antitrypsin deficiency
Mary: Signs and symptoms of emphysema
- incr. residual vol.
- Incr. WOB/laboured breathing
- SOB/SOB on exertion
- Dyspnoea (nostril flaring, incr. use of accessory mm)
- productive cough
(barrel-shaped chest, hyperinflation of lungs) - Hyperventilation
- Incr. RR
- Finger clubbing
Mary:
Patho of emphysema: initiation + development
- Enlargement of gas exchange airways + alveolar wall destruction
- due to exposure to irritants or a1-antitrypsine deficiency - Inflammation, oxidative stress, incr. proteases, and decr. antiproteases
- Incr. alveolar tissue destruction (alveolar walls, septa, capillaries), decr. tissue repair, breakdown of elastic fibers
- Alveolar space enlargement –> decr. SA for gas exchange
Decr. elastin –> decr. recoil/radial traction - Air trapping (related to collapse of the small bronchioles during early expiration and the lack of recoil) and decr. gas exchange
- Expiration becomes more difficult + hyperinflation occurs
–> pursed lip expiration, prolonged expiration
–> incr. ventilation rate - Eventually hypoventilation occurs
–> hypoxemia + hypercapnia
Mary:
Patho of emphysema: systemic implications of air trapping/decr. gas exchange
- Hypoxemia –> incr. anaerobic respiration –> incr. lactic acid –> metabolic acidosis
Hypercapnia –> respiratory acidosis - Tissue ischemia and hypoxia
- Pulmonary hypoxia –> vasoconstriction –> pulmonary hypertension + incr. pulmonary vascular resistance (PVR)
- Right side heart failure - cor pulmonale (bc it has to work harder)
- Atelectasis (alveolar collapse)
Mary: Differences in patho bw chronic bronchitis and emphysema and asthma
Emphysema:
- alveolar membrane (and capillary) destruction –> V/Q (ventilation/blood flow) matched initially –> decr. gas exchange
- loss of elastin
- Compromised exhalation; pursed lip breathing
Chronic bronchitis:
- inflammation of the bronchioles w mucus hypersecretion (acute is usually due to infection) –> incr. airway resistance –> V/Q mismatch bc not enough air coming into alveolar spaces –> decr. gas exchange
- clogging up of airways w mucus
- Chronic cough
Asthma:
- inflamed and narrow bronchiolar smooth muscle
Mary: What drugs was Mary prescribed and what do they do?
- Supplementary oxygen: decr. dyspnoea, prevent hypoxia, aid brochodilation
- Sympathomimetics (beta agonists)(inhalers/relievers): e.g. salbutamol (short-acting), salmeterol (long acting). Dilation. Act on receptors on bronchiole smooth muscle to open the airways.
- Corticosteroids: e.g. hydrocortisone, prednisone. Decr. inflammatory response
- Anticholinergics: e.g. Ipratropium. block mACh receptors on bronchiole smooth muscle to cause broncodilation
Mary: Describe the tests/evaluations used in COPD
- Peak expiratory flow (PEF): measures how quickly you can exhale
- Forced expiratory volume (FEV): tests how much air you can exhale in 1sec
Also - Arterial blood gases and pH: checks O2 status and acid balance
- Pulse oximetry: estimates O2 content in arterial blood
- Body plethysmography: measures thoracic vol. and airway resistance
- Diffusing capacity: tests O2 transfer from the alveoli to circulation
- Sputum sample: diagnoses bacterial lung infection
- Chest X-ray
Mike: Signs and symptoms of MI
- Nausea/vomiting
- Severe, sudden onset of pain (prolonged, not responsive to rest or medications)
- Feeling of impending doom
- Tightness/restriction/discomfort in chest
- Pallor or cool peripheries
- Sweating
- ECG changes
- Elevated cardiac enzymes (CK or CPK, CK-MB, troponin I & T)
Mike: Risk factors for Myocardial Infarction
- smoking
- Obesity
- Incr. age
- Diet (hypercholesteremia/hyperlipidemia)
- Family history
- Diabetes
- Physical inactivity
- Sex (male is incr.)
- Cardiovascular conditions
○ Atherosclerosis
○ Hypertension
Mike
Pathophysiology of MI: initial cascade, tissues directly affected
- Blockage of coronary arteries
- Myocardial ischemia and hypoxia
- Myocardial necrosis
Subendocardial: only the myocardium just below the endocardium
Transmural: full thickness of myocardium (caused by permanent blockage) - Myocardial cells breakdown (sarcolemma) and coagulation
- Leakage of cardiac enzymes (contractile proteins) from the cells (particularly troponin, which is used to indicate MI by testing levels in the blood)
- Ventricular dysfunction –> inadequate supply to the body
Mike:
Pathophysiology of MI: effects on surrounding tissue (i.e. not starved of O2)
- Myocardial stunning: myocytes temporarily lose contractility
- Myocardial hibernation: myocytes preserve themselves by stopping their contractility (decr. Energy needs) in the hopes to regain ability later on
- Myocardial remodeling: remodeled to not be able to contract in order to preserve themselves
Mike: Complications of MI
Necrotic tissue replaced w fibrous tissue (not contractile) which causes: ○ Arrythmias ○ Ventricular fibrillation ○ Ventricular failure ○ Valvular incompetence ○ Aneurysm ○ Pericarditis
Mike: Describe tests/evaluations for MI
- ECG
- Measures the electroactivity of the heart using voltage over time
- reflects origin of heartbeat and conduction of electrical impulse
- Must be performed during an episode of angina
- Transient ST segment depression and T wave inversion are characteristic signs of subendocardial ischemia; ST elevation indicates transmural ischemia
- Used to: detect abnormal heart rhythms; detect heart problems; monitor recovery from a heart attack - Angiogram
- assesses whether there is damage to the arteries that supply the heart since impaired blood flow to the heart muscles can be a primary cause of chest pain.
- inject a contrast agent into the bloodstream, which makes the blood vessels surrounding the heart visible on an x-ray. - GCS
- used to describe the level of consciousness in a person
- used to help gauge the severity of an acute brain injury. - Other tests:
- FBC, BG, electrolytes, cardiac enzymes (troponin T: contractile protein that is only released when myocardial necrosis occurs, measure 10-12hrs after onset of symptoms, ref range is 0-0.03; early marker = myoglobin), thyroid function tests
Mike: Management of MI
immediate treatment + those prescribed upon discharge
Main goals:
- decr. heart workload
- Incr. O2
- Reperfusion
Immediate management:
- Oxygen (if O2% less than 92)
- Aspirin
- Nitroglycerine (resolves chest pain by relaxing vascular smooth-muscle beds. Works well on coronary arteries, improving blood flow to ischemic areas)
- Morphine (additional pain relief if GTN doesn’t work. Also a venodilator, reducing ventricular preload and cardiac oxygen requirements)
Discharge meds:
○ Aspirin (anticoagulant, prevents clots)
○ Statins (decrease cholesterol synthesis in the liver)
○ Beta blockers/metoprolol (decr. BP, CO, HR/hypertension)
○ GTN (vasodilation and reduces preload and afterload, resulting in decreased cardiac workload)
○ Clopidogrel (anticoagulant, platelet aggregate inhibitor)
Barry: Risk factors for stroke
Hypertension Diabetes Incr. age smoking, alcohol and drugs poor diet (hyperlipidemia/hypercholesterolemia) obesity physical inactivity sex atherosclerosis thromboembolism family history/genetics
Barry:
Signs and symptoms of stroke
Facial droop
Arm weakness
Slurred speech/difficulty
Barry: Pathophysiology of ischemic stroke, incl. atherosclerosis
- blockage in a cerebral blood vessel, resulting in ischemia and hypoxia of a part of the brain –> neural tissue necrosis and dysfunction.
2 types:
1. Thrombotic - thrombus formation within the cerebral artery/ies supplying blood to the brain. Usually due to plaque formation (most commonly atherosclerosis).
2. Embolic - thrombus formed elsewhere (usually heart), dislodges then becomes lodged in brain
Atherosclerosis:
1. Endothelial injury + inflammation
2. LDL enters endothelium (+ cytokine release)
3. Foam cell production (as macrophages engulf LDL molecules) + accumulation in endothelium
4. Fatty streak formation
5. Smooth muscle cell proliferation and migration into plaque
6. Collagen produced over plaque to form a fibrous plaque
7. Plaque either
(A) decreases BV diameter –> ischemia
(B) rupture, leaving underlying tissue exposed to lumen, causing platelet adhesion + coagulation initiation, forming thrombus which leads to occlusion (ischemia + infarction)
Barry: Difference bw ischemic and hemorrhagic stroke
- Ischemic
- blocked cerebral artery –> ischemia - Hemorrhagic
- breakage of cerebral blood vessel, resulting in bleeding.
Barry: patho of plaque formation and atherosclerosis
- Injured endothelium becomes inflamed
- Cytokines further injure endothelium
- Smooth muscles grows and cells migrate into plaque forming fibrous plaque over fatty streak
- Growing plaque decr. blood vessel diameter –> ischemia/limited perfusion
- Plaques may rupture, exposing underlying tissue to lumen of vessel –> platelet adhesion and coagulation –> thrombus formation
- thrombus occludes artery –> ischemia and infarction
Barry: describe the GCS
- 3 components
- how it’s scored
- what the score means in terms of injury
Score bw 3-15 (contextual) ○ Eye Opening - Spontaneous (4) - Verbal/sound (3) - Pain/pressure (2) - None (1) ○ Verbal response - Orientated (5) - Confused (4) - Words (3) - Sounds (2) - None (1) ○ Motor response - Obeys command (6) - Localized (5) e.g. in the general area of the stimulus - Normal flexion (4) e.g. towards the stimulus - Abnormal flexion (3) e.g. away from the stimulus - Extension (2) - None (1)
Severity of TBI
Mild: 13-15
Moderate: 9-12
Severe: 3-8
Barry: Outline the other neurological exams (apart from the GCS) that were done for Barry
○ Visual field (peripheral vision): measuring when he could see the pen from his right side. Took a while, had to be in the center of his eye
○ Facial movement: significant weakness/limited movement on the right side of his face. Visible drooping
○ Facial sensation: limited sensation in the right side of his face
○ Corneal reflex: did NOT exhibit a corneal reflex with his right eye.
○ Leg movement: could lift both his right and left legs, though there was apparent weakness in his right leg.
○ Arm movement: significant weakness is his right arm and was unable to lift it.
Barry: treatments for stroke
For rtPA:
- what it is
- what it does/MOA
- when it’s used
- risks
- contraindications
- Anti-Coagulants (e.g. aspirin, heparin, warfarin)
- Antihypertensives (e.g. metoprolol, cilazapril, Clonodine, Frusemide)
- Reperfusion: rtPA - fibrinolytic
○ tissue plasminogen activator, an enzyme
○ turns plasminogen into plasmin, which breaks down fibrin (blood clots); reverses any coagulation
○ used asap to treat an acute ISCHEMIC stroke, NOT a hemorrhagic stroke
○ Uncontrollable bleeding and fatality
○ recent major surgery, myocardial infarction, stroke, or other internal injuries, pre-existing coagulation/bleeding disorder, significant hypertension, any other bleeding risks
Ben: Type 1 vs type 2 diabetes
○ Type 1: no effective insulin production; autoimmune destruction of pancreatic beta cells
○ Type 2: insulin resistance + some decr. Insulin production
Ben: risk factors for T2 diabetes
- Obesity!!
- Pancreatitis
- Smoking
- Family history
- Gestational diabetes mellitus
- Poor diet + inactivity
- Sedentary lifestyle
- hypercholesteremia or hyperlipidemia